Platinum-resistant ovarian cancer (PROC) remains one of the most significant challenges in gynecologic oncology; however, novel antibody-drug conjugates (ADCs) and innovative investigational therapies are opening new avenues to improve outcomes.

Novel targeted therapies offer new hope to slow progression and improve quality of life in meaningful ways for patients with primary biliary cholangitis (PBC).

Join us for a live webinar focused on the evolving role of immunotherapy in early-stage resectable non-small cell lung cancer (NSCLC).

Join us for our 3-day head-to-toe sports medicine conference. We are excited to again offer two tracks in our conference, one for primary care providers and one for athletic trainers and physical therapists.

Post-COVID conditions (PCC) refer to a diverse array of symptoms that persist for weeks, months, and even years after acute SARS-CoV-2 infection and significantly impact quality of life.

This innovative program will provide a practical update on a full range of common but controversial issues in women’s health. Emphasis will be placed on new developments in preventive care, issues in reproductive health, clinical strategies.

Longstanding barriers to care combined with an elevated risk of diabetic macular edema (DME) contribute to the disproportionate burden of DME in Native American communities.

This course presents topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice across a variety of cardiologic subspecialty interests.

Bipolar disorder (BD) is a chronic and disabling mood disorder often complicated by overlapping symptoms, frequent misdiagnosis, poor adherence, and comorbidities, leaving significant gaps in care.

Enhance your expertise in MASH diagnosis and management with this preceptorship. Join us for a two-part training experience that will elevate your skills and connect you with liver-focused professionals. Part I is virtual; Part II is in-clinic.